Keratinocyte-Associated B7-H1 Directly Regulates Cutaneous Effector CD8+ T Cell Responses
暂无分享,去创建一个
[1] Frank O. Nestle,et al. Skin immune sentinels in health and disease , 2009, Nature Reviews Immunology.
[2] M. Azuma,et al. Identification of three distinct subsets of migrating dendritic cells from oral mucosa within the regional lymph nodes , 2009, Immunology.
[3] S. Gambhir,et al. Lymphoid-tissue-specific homing of bone-marrow-derived dendritic cells. , 2009, Blood.
[4] R. Fairchild,et al. CD8 T Cells Producing IL-17 and IFN-γ Initiate the Innate Immune Response Required for Responses to Antigen Skin Challenge1 , 2009, The Journal of Immunology.
[5] M. Azuma,et al. The Glucocorticoid-Induced TNF Receptor-Related Protein (GITR)-GITR Ligand Pathway Acts As a Mediator of Cutaneous Dendritic Cell Migration and Promotes T Cell-Mediated Acquired Immunity1 , 2009, The Journal of Immunology.
[6] J. Dutz. T-cell-mediated injury to keratinocytes: insights from animal models of the lichenoid tissue reaction. , 2009, The Journal of investigative dermatology.
[7] G. Freeman,et al. Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway. , 2008, Blood.
[8] D. Chang,et al. Protective Role of Programmed Death 1 Ligand 1 (PD-L1)in Nonobese Diabetic Mice , 2008, Diabetes.
[9] M. Azuma,et al. Topical application of cream-emulsified CD86 siRNA ameliorates allergic skin disease by targeting cutaneous dendritic cells. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[10] G. Freeman,et al. PD-1 and its ligands in tolerance and immunity. , 2008, Annual review of immunology.
[11] Lieping Chen,et al. Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7‐homolog 1‐dependent CD8+ T cell tolerance , 2007, Hepatology.
[12] G. Freeman,et al. The Function of Donor versus Recipient Programmed Death-Ligand 1 in Corneal Allograft Survival1 , 2007, The Journal of Immunology.
[13] L. Jones,et al. Human keratinocyte induction of rapid effector function in antigen‐specific memory CD4+ and CD8+ T cells , 2007, European journal of immunology.
[14] A. Iwasaki. Mucosal dendritic cells. , 2007, Annual review of immunology.
[15] F. Vincenti,et al. T cell costimulation: a rational target in the therapeutic armamentarium for autoimmune diseases and transplantation. , 2007, Annual review of medicine.
[16] Yi-hong Wang,et al. Cutting Edge: Programed Death (PD) Ligand-1/PD-1 Interaction Is Required for CD8+ T Cell Tolerance to Tissue Antigens1 , 2006, The Journal of Immunology.
[17] J. Bluestone,et al. Insulin-induced remission in new-onset NOD mice is maintained by the PD-1–PD-L1 pathway , 2006, The Journal of experimental medicine.
[18] K. Okumura,et al. B7-H1-Induced Apoptosis as a Mechanism of Immune Privilege of Corneal Allografts1 , 2006, The Journal of Immunology.
[19] G. Freeman,et al. Reinvigorating exhausted HIV-specific T cells via PD-1–PD-1 ligand blockade , 2006, The Journal of experimental medicine.
[20] Philip J. R. Goulder,et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression , 2006, Nature.
[21] L. Lefrançois,et al. Intestinal and pulmonary mucosal T cells: local heroes fight to maintain the status quo. , 2006, Annual review of immunology.
[22] R. Ahmed,et al. Restoring function in exhausted CD8 T cells during chronic viral infection , 2006, Nature.
[23] M. Isobe,et al. Blockade of the Interaction Between PD-1 and PD-L1 Accelerates Graft Arterial Disease in Cardiac Allografts , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[24] K. Omura,et al. The expression of B7-H1 on keratinocytes in chronic inflammatory mucocutaneous disease and its regulatory role. , 2004, Immunology letters.
[25] G. Zhu,et al. B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes. , 2004, Immunity.
[26] Lieping Chen,et al. Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection. , 2004, The Journal of clinical investigation.
[27] G. Freeman,et al. Endothelial expression of PD‐L1 and PD‐L2 down‐regulates CD8+ T cell activation and cytolysis , 2003, European journal of immunology.
[28] S. Khoury,et al. The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice , 2003, The Journal of experimental medicine.
[29] T. Curiel,et al. Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity , 2003, Nature Medicine.
[30] D. Pardoll,et al. Expression of Programmed Death 1 Ligands by Murine T Cells and APC1 , 2002, The Journal of Immunology.
[31] Yoshimasa Tanaka,et al. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[32] J. Kehren,et al. Skin Inflammation During Contact Hypersensitivity Is Mediated by Early Recruitment of CD8+ T Cytotoxic 1 Cells Inducing Keratinocyte Apoptosis1 , 2002, The Journal of Immunology.
[33] H. Hashimoto,et al. Preferential Blockade of CD8+ T Cell Responses by Administration of Anti-CD137 Ligand Monoclonal Antibody Results in Differential Effect on Development of Murine Acute and Chronic Graft-Versus-Host Diseases1 , 2001, The Journal of Immunology.
[34] T. Luger,et al. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity. , 1995, Journal of immunology.
[35] L. Turka,et al. Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes. , 1994, Immunology today.
[36] C. Thompson,et al. Keratinocyte-derived T cell costimulation induces preferential production of IL-2 and IL-4 but not IFN-gamma. , 1994, Journal of immunology.
[37] C. Thompson,et al. Accessory cell function of keratinocytes for superantigens. Dependence on lymphocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction. , 1993, Journal of immunology.
[38] R. Steinman,et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor , 1992, The Journal of experimental medicine.
[39] T. Honjo,et al. Induced expression of PD‐1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. , 1992, The EMBO journal.
[40] A. Enk,et al. Early molecular events in the induction phase of contact sensitivity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[41] A. Gaspari,et al. Induction of in vivo hyporesponsiveness to contact allergens by hapten-modified Ia+ keratinocytes. , 1991, Journal of immunology.
[42] R. Steinman,et al. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro , 1985, The Journal of experimental medicine.
[44] Shih-Hua Lin,et al. Protective Role of Programmed Death 1 Ligand 1 in Nonobese Diabetic Mice: The Paradox in Transgenic Models , 2008 .
[45] G. Freeman,et al. The B7 family revisited. , 2005, Annual review of immunology.
[46] 津島 文彦. Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses , 2003 .
[47] G. Zhu,et al. Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion , 2002, Nature Medicine.
[48] J. Bluestone,et al. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. , 2001, Annual review of immunology.